Collaborative efforts between the two Horizon 2020 projects to standardize methods and investigate the health impacts of indoor microplastic pollution. 

Two scientific collaborations, IMPTOX and EDIAQI, have joined forces to conduct research on microplastics found in indoor environments. IMPTOX primarily focuses on investigating the toxicity of micro- and nano-plastic particles (MNPs) and their impact on the risk of allergic diseases. On the other hand, EDIAQI (Evidence Driven Air Quality Improvement) concentrates on monitoring indoor air quality and studying the harmful effects of indoor air pollution on asthma and allergies. Both projects are funded through the Horizon Europe framework program and have agreed to collaborate on two main areas:

1. Developing standardized methods for characterizing microplastics and collecting samples.
2. Exploring the biological and chemical pollution associated with microplastics found indoors.

To facilitate this collaboration, a working group comprising chemical and medical scientists from both projects will be formed. Additionally, IMPTOX and EDIAQI share a common partner, the Children's Hospital Srebrnjak, which serves as the home to both research cohorts. This shared partnership will enhance our understanding of how these pollutants and their combined effects may influence the health of children.